Fig. 1From: Effect of neoadjuvant therapy on breast cancer biomarker profileChanges of biomarker expression in biopsy and surgical samples, in the no-NAT group. Points indicate the median value for each measure. ER: Estrogen receptor; PR: Progesterone receptorBack to article page